Clare Xu

Clare Xu, Ph.D. has a diverse work experience that spans various roles and industries. Clare is currently the Director of Corporate Development at Kodiak Sciences since February 2022. Prior to this, they worked at Regeneron Pharmaceuticals, Inc. as an Associate Director of Corporate Strategy from March 2020 to January 2022. Clare also has experience in consulting, having worked at L.E.K. Consulting as a Consultant from October 2019 to February 2020, and as a Senior Life Sciences Specialist from October 2018 to September 2019. Clare initially joined L.E.K. Consulting as a Life Sciences Specialist from October 2017 to September 2018. Before transitioning to the corporate world, Clare worked as a Research Mentor at Boston Children's Hospital in 2015. Clare also gained teaching experience as a Graduate Teaching Assistant for Genetics at Harvard Medical School from September 2013 to December 2013. Overall, Clare Xu, Ph.D. has a strong background in corporate development, strategy, consulting, research, and teaching.

Clare Xu, Ph.D., has an extensive education history. Clare obtained their Bachelor of Arts (B.A.) degree in Biochemistry, Summa cum Laude, from Mount Holyoke College, where they studied from 2008 to 2012. Clare then pursued their Doctor of Philosophy (PhD) in Biological and Biomedical Sciences at Harvard University from 2012 to 2017. Additionally, they attended Harvard Business School for specialized coursework. In 2015, they completed a field course titled "Commercializing Science," and in 2016, they completed a Mini-MBA program. With a strong background in both science and business, Clare Xu has a diverse skill set that combines their expertise in both fields.